357 related articles for article (PubMed ID: 34712223)
1. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
Lauriero G; Abbad L; Vacca M; Celano G; Chemouny JM; Calasso M; Berthelot L; Gesualdo L; De Angelis M; Monteiro RC
Front Immunol; 2021; 12():694787. PubMed ID: 34712223
[TBL] [Abstract][Full Text] [Related]
2. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
Monteiro RC; Rafeh D; Gleeson PJ
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456735
[TBL] [Abstract][Full Text] [Related]
4. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
5. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
Abbad L; Monteiro RC; Berthelot L
Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400
[TBL] [Abstract][Full Text] [Related]
6. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.
Chemouny JM; Gleeson PJ; Abbad L; Lauriero G; Boedec E; Le Roux K; Monot C; Bredel M; Bex-Coudrat J; Sannier A; Daugas E; Vrtovsnik F; Gesualdo L; Leclerc M; Berthelot L; Ben Mkaddem S; Lepage P; Monteiro RC
Nephrol Dial Transplant; 2019 Jul; 34(7):1135-1144. PubMed ID: 30462346
[TBL] [Abstract][Full Text] [Related]
8. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports.
Zhao J; Bai M; Yang X; Wang Y; Li R; Sun S
Ren Fail; 2021 Dec; 43(1):928-933. PubMed ID: 34134605
[TBL] [Abstract][Full Text] [Related]
10. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
11. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
[TBL] [Abstract][Full Text] [Related]
12. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
13. The Gut-Renal Connection in IgA Nephropathy.
Coppo R
Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1via the TLR4 signaling pathway.
Zhu Y; He H; Sun W; Wu J; Xiao Y; Peng Y; Hu P; Jin M; Liu P; Zhang D; Wu J; Xie T; Huang L; He W; Wei M; Wang L; Xu X; Tang Y
Nephrol Dial Transplant; 2024 Feb; ():. PubMed ID: 38402460
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic significance of IgA receptor interactions in IgA nephropathy.
Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M
Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.
Hu X; Du J; Xie Y; Huang Q; Xiao Y; Chen J; Yan S; Gong Z; Ouyang S
BMC Nephrol; 2020 Mar; 21(1):97. PubMed ID: 32169051
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy.
Tang Y; Xiao Y; He H; Zhu Y; Sun W; Hu P; Xu X; Liu Z; Yan Z; Wei M
Kidney Blood Press Res; 2023; 48(1):261-276. PubMed ID: 36878203
[TBL] [Abstract][Full Text] [Related]
18. Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?
Boyd JK; Barratt J
Kidney Int; 2010 Dec; 78(12):1211-3. PubMed ID: 21116273
[TBL] [Abstract][Full Text] [Related]
19. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model.
Di Leo V; Gleeson PJ; Sallustio F; Bounaix C; Da Silva J; Loreto G; Ben Mkaddem S; Monteiro RC
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33923466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
